Seattle, WA, United States of America

Yashwanth Nanda Kumar

This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yashwanth Nanda Kumar: Innovator in Tissue-Mimicking Hydrogel Materials

Introduction

Yashwanth Nanda Kumar is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biomedical engineering, particularly in the development of materials that mimic biological tissues. His innovative work has the potential to advance medical research and applications.

Latest Patents

Yashwanth holds a patent for a tissue-mimicking hydrogel material, which serves as a phantom for fibrous tissue. This phantom is formed from a precursor solution that includes approximately 30-90 wt % of water, acrylamide, and alginate. The combination of acrylamide and alginate constitutes about 10 to 70 wt % of the precursor solution, with a specific ratio of acrylamide to alginate ranging from about 60:40 to about 99:1 w/w. This invention is crucial for simulating biological environments in research settings.

Career Highlights

Yashwanth is affiliated with the University of Washington, where he continues to explore innovative solutions in material science. His work is characterized by a commitment to enhancing the understanding of tissue properties and their applications in medical technology.

Collaborations

Yashwanth collaborates with Adam D Maxwell, contributing to the advancement of research in their field. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Yashwanth Nanda Kumar is a notable inventor whose work in tissue-mimicking hydrogel materials is paving the way for advancements in biomedical research. His contributions are significant and reflect a dedication to improving medical technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…